Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8325)
All Articles published online
|
Publishing Process of This Article
|
Nov 28, 2013 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pompili M, Biolato M, Miele L, Grieco A. Tumor necrosis factor-α inhibitors and chronic hepatitis C: A comprehensive literature review. World J Gastroenterol 2013; 19(44): 7867-7873 [PMID: 24307780 DOI: 10.3748/wjg.v19.i44.7867] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i44/7867.htm |
| Number | Citing Articles |
| 1 |
Mi Ryoung Seo, Gunwoo Kim, Ki Won Moon, Yoon-Kyoung Sung, Jong Jin Yoo, Chong-Hyeon Yoon, Eun Bong Lee, Jisoo Lee, Eun Ha Kang, Hyungjin Kim, Eun-Jung Park, Wan-Sik Uhm, Myeung Su Lee, Seung-Won Lee, Byoong Yong Choi, Seung-Jae Hong, Han Joo Baek. Quality Indicators for Evaluating the Health Care of Patients with Rheumatoid Arthritis: a Korean Expert Consensus. Journal of Korean Medical Science 2021; 36(17) doi: 10.3346/jkms.2021.36.e109
|
| 2 |
Christine S. Ahn, Emily H. Dothard, Michael L. Garner, Steven R. Feldman, William W. Huang. To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis. Journal of the American Academy of Dermatology 2015; 73(3): 420 doi: 10.1016/j.jaad.2015.06.004
|
| 3 |
Dorcas Ohui Owusu, Richard Phillips, Michael Owusu, Fred Stephen Sarfo, Margaret Frempong. Increased levels of circulating IL-10 in persons recovered from hepatitis C virus (HCV) infection compared with persons with active HCV infection. BMC Research Notes 2020; 13(1) doi: 10.1186/s13104-020-05313-w
|
| 4 |
Enrique Rodríguez de Santiago, Agustín Albillos Martínez, Antonio López-Sanromán. Infecciones en la enfermedad inflamatoria intestinal. Medicina Clínica 2017; 148(9): 415 doi: 10.1016/j.medcli.2016.12.041
|
| 5 |
Philipp Schulte-Terhusen, Xenofon Baraliakos, Dimitra Karagkiozidou. Arthralgien bei Psoriasis vulgaris – manchmal lohnt ein zweiter Blick. DMW - Deutsche Medizinische Wochenschrift 2024; 149(03): 102 doi: 10.1055/a-2199-1549
|
| 6 |
Hsien-Yi Chiu, Ying-Ming Chiu, Nien-Feng Chang Liao, Ching-Chi Chi, Tsen-Fang Tsai, Chang-Yu Hsieh, Tsu-Yi Hsieh, Kuo-Lung Lai, Tsu-Man Chiu, Nan-Lin Wu, Rosaline Chung-yee Hui, Chaw-Ning Lee, Ting-Shun Wang, Po-Hua Chen, Chao-Chun Yang, Yu-Huei Huang. Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study. Journal of the American Academy of Dermatology 2021; 85(2): 337 doi: 10.1016/j.jaad.2019.12.001
|
| 7 |
J.M. Carrascosa, M. Galán, R. de Lucas, A. Pérez-Ferriols, M. Ribera, I. Yanguas. Recomendaciones de expertos para el tratamiento de la psoriasis en situaciones especiales (II). Actas Dermo-Sifiliográficas 2016; 107(9): 712 doi: 10.1016/j.ad.2016.04.017
|
| 8 |
Lorne Schweitzer, Victoria Korsos, Donald C. Vinh. Encyclopedia of Infection and Immunity. 2022; : 819 doi: 10.1016/B978-0-12-818731-9.00175-0
|
| 9 |
Sara Massironi, Lorena Pirola, Giacomo Mulinacci, Antonio Ciaccio, Chiara Viganò, Andrea Palermo, Alessandra Zilli, Pietro Invernizzi, Silvio Danese. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks. Inflammatory Bowel Diseases 2023; 29(9): 1477 doi: 10.1093/ibd/izac189
|
| 10 |
Monica Salvi, Laura Macaluso, Cecilia Luci, Carlo Mattozzi, Giovanni Paolino, Yvonne Aprea, Stefano Calvieri, Antonio Giovanni Richetta. Safety and efficacy of anti-tumor necrosis factors α in patients with psoriasis and chronic hepatitis C. World Journal of Clinical Cases 2016; 4(2): 49-55 doi: 10.12998/wjcc.v4.i2.49
|
| 11 |
Alexandr Zinchuk, Oleksandr Herasun, Andrij Zadorozhnyi, Olga Vorozhbyt, Borys Gerasun. INFLUENCE OF AUTOLEUKOCYTE VACCINATION ON ACTIVITY LEVEL OF TUMOR NECROSIS FACTOR ALPHA IN PATIENTS WITH CHRONIC HEPATITIS B. Wiadomości Lekarskie 2019; 72(1): 31 doi: 10.36740/WLek201901106
|
| 12 |
Elías Forero, Monique Chalem, Gloria Vásquez, Edwin Jauregui, Luis Fernando Medina, Luis Fernando Pinto Peñaranda, John Medina, Yimy Medina, Diego Jaimes, Ana Milena Arbelaez, Aura María Domínguez, Andrés Fernández, Oscar Jair Felipe-Díaz, Philippe Chalem, Carlo Vinicio Caballero Uribe, María José Jannaut, Ixhel García, Wilson Bautista, Javier Ramírez Figueroa, Jorge Cortés, Jorge Quintero, Nohora Rodríguez. Risk management for prescribing biological therapies. Revista Colombiana de Reumatología (English Edition) 2016; 23(1): 50 doi: 10.1016/j.rcreue.2016.05.003
|
| 13 |
Chi Chiu Mok. Hepatitis B and C infection in patients undergoing biologic and targeted therapies for rheumatic diseases. Best Practice & Research Clinical Rheumatology 2018; 32(6): 767 doi: 10.1016/j.berh.2019.03.008
|
| 14 |
Marco Sebastiani, Laura Milazzo, Fabiola Atzeni, Caterina Vacchi, Andreina Manfredi, Luca Quartuccio, Carlo Scirè, Giovanni Battista Gaeta, Giovanni Lapadula, Orlando Armignacco, Marcello Tavio, Salvatore D’Angelo, Pierluigi Meroni, Laura Bazzichi, Walter Grassi, Alessandro Mathieu, Claudio Mastroianni, Evangelista Sagnelli, Teresa Santantonio, Caterina Uberti Foppa, Massimo Puoti, Loredana Sarmati, Paolo Airò, Oscar Massimiliano Epis, Rossana Scrivo, Miriam Gargiulo, Agostino Riva, Giovanni Ciancio, Gianguglielmo Zehender, Gloria Taliani, Luca Meroni, Salvatore Sollima, Piercarlo Sarzi-Puttini, Massimo Galli. Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis. Modern Rheumatology 2019; 29(6): 895 doi: 10.1080/14397595.2018.1558918
|
| 15 |
Gabriel L. Costa, Giuseppe A. Sautto. Exploring T-Cell Immunity to Hepatitis C Virus: Insights from Different Vaccine and Antigen Presentation Strategies. Vaccines 2024; 12(8): 890 doi: 10.3390/vaccines12080890
|
| 16 |
Kyung-Su Park. Chronic Hepatitis C Virus Infection, Why Not Treat Now?. Journal of Rheumatic Diseases 2018; 25(3): 151 doi: 10.4078/jrd.2018.25.3.151
|
| 17 |
Jasvinder A. Singh, Kenneth G. Saag, S. Louis Bridges, Elie A. Akl, Raveendhara R. Bannuru, Matthew C. Sullivan, Elizaveta Vaysbrot, Christine McNaughton, Mikala Osani, Robert H. Shmerling, Jeffrey R. Curtis, Daniel E. Furst, Deborah Parks, Arthur Kavanaugh, James O'Dell, Charles King, Amye Leong, Eric L. Matteson, John T. Schousboe, Barbara Drevlow, Seth Ginsberg, James Grober, E. William St.Clair, Elizabeth Tindall, Amy S. Miller, Timothy McAlindon. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis & Rheumatology 2016; 68(1): 1 doi: 10.1002/art.39480
|
| 18 |
Hebah Alhajeri, Fatemah Abutiban, Wasl Al-Adsani, Adel Al-Awadhi, Ali Aldei, Ahmad AlEnizi, Naser Alhadhood, Adeeba Al-Herz, Waleed Alkandari, Ahmad Dehrab, Aqeel A. Muhanna Ghanem, Eman Hasan, Sawsan Hayat, Khulood Saleh, Hoda Tarakmeh, Yaser Ali. Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis. Rheumatology International 2019; 39(9): 1483 doi: 10.1007/s00296-019-04372-y
|
| 19 |
Philipp Schulte-Terhusen, Xenofon Baraliakos, Dimitra Karagkiozidou. Arthralgien bei Psoriasis vulgaris – manchmal lohnt ein zweiter Blick. Aktuelle Dermatologie 2024; 50(11): 517 doi: 10.1055/a-2328-7454
|
| 20 |
Devis Pascut, Minh Hoang, Nhu N. Q. Nguyen, Muhammad Yogi Pratama, Claudio Tiribelli. HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development. Cancers 2021; 13(10): 2485 doi: 10.3390/cancers13102485
|
| 21 |
Zohreh Jadali. Safety of Anti-TNF-α Therapy in Patients With Psoriasis and Concomitant Hepatitis C Virus Infection. Journal of Skin and Stem Cell 2015; 2(1) doi: 10.17795/jssc30058
|
| 22 |
Nicola Imperatore, Fabiana Castiglione, Antonio Rispo, Anna Sessa, Nicola Caporaso, Filomena Morisco. Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00867
|
| 23 |
Azeen Sadeghian, Virginia Alldredge, Ardalan Minokadeh, Erin Boh. A Clinician's Guide to Diagnosing and Managing Psoriatic Arthritis. Journal of Psoriasis and Psoriatic Arthritis 2015; 1(1): 9 doi: 10.1177/247553031500100103
|
| 24 |
Ayman Abdelmaksoud, Michelangelo Vestita. Direct acting antiviral‐induced/exacerbated psoriasis: Addendum!. Dermatologic Therapy 2019; : e12929 doi: 10.1111/dth.12929
|
| 25 |
Johannes Zeller, Steffen U. Eisenhardt. Regenerative Medicine and Plastic Surgery. 2019; : 173 doi: 10.1007/978-3-030-19958-6_17
|
| 26 |
Paula Sousa, Matthieu Allez. Complications of biologics in inflammatory bowel disease. Current Opinion in Gastroenterology 2015; 31(4): 296 doi: 10.1097/MOG.0000000000000191
|
| 27 |
Milton Roy, Rajesh Singh. TRIMs: selective recruitment at different steps of the NF-κB pathway—determinant of activation or resolution of inflammation. Cellular and Molecular Life Sciences 2021; 78(17-18): 6069 doi: 10.1007/s00018-021-03900-z
|
| 28 |
Monica I. Ardura, Sima S. Toussi, Jane D. Siegel, Ying Lu, Athos Bousvaros, Wallace Crandall. NASPGHAN Clinical Report. Journal of Pediatric Gastroenterology and Nutrition 2016; 63(1): 130 doi: 10.1097/MPG.0000000000001188
|
| 29 |
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Elena Penza, Ottavia Magnani, Francesco Puppo. Infection risk associated with anti-TNF-α agents: a review. Expert Opinion on Drug Safety 2015; 14(4): 571 doi: 10.1517/14740338.2015.1009036
|
| 30 |
Simone Garcovich, Matteo Garcovich, Rodolfo Capizzi, Antonio Gasbarrini, Maria Assunta Zocco. Cutaneous manifestations of hepatitis C in the era of new antiviral agents. World Journal of Hepatology 2015; 7(27): 2740-2748 doi: 10.4254/wjh.v7.i27.2740
|
| 31 |
Wenshi Wang, Lei Xu, Johannes H. Brandsma, Yijin Wang, Mohamad S. Hakim, Xinying Zhou, Yuebang Yin, Gwenny M. Fuhler, Luc J. W. van der Laan, C. Janneke van der Woude, Dave Sprengers, Herold J. Metselaar, Ron Smits, Raymond A. Poot, Maikel P. Peppelenbosch, Qiuwei Pan. Convergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV. Scientific Reports 2016; 6(1) doi: 10.1038/srep25482
|
| 32 |
Joshua S. Davis, David Ferreira, Emma Paige, Craig Gedye, Michael Boyle. Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies. Clinical Microbiology Reviews 2020; 33(3) doi: 10.1128/CMR.00035-19
|
| 33 |
Renée M. Marchioni Beery, Joshua R. Korzenik. Treatment of Inflammatory Bowel Disease with Biologics. 2018; : 185 doi: 10.1007/978-3-319-60276-9_12
|
| 34 |
Patrick R. Wood, Liron Caplan. Drug-Induced Gastrointestinal and Hepatic Disease Associated with Biologics and Nonbiologic Disease-Modifying Antirheumatic Drugs. Rheumatic Disease Clinics of North America 2018; 44(1): 29 doi: 10.1016/j.rdc.2017.09.003
|
| 35 |
M. Elaine Husni. Comorbidities in Psoriatic Arthritis. Rheumatic Disease Clinics of North America 2015; 41(4): 677 doi: 10.1016/j.rdc.2015.07.008
|
| 36 |
Lai Shan Tam, James Cheng‐Chung Wei, Amita Aggarwal, Han Joo Baek, Peter P. Cheung, Praveena Chiowchanwisawakit, Leonila Dans, Jieruo Gu, Noboru Hagino, Mitsumasa Kishimoto, Heizel Manapat Reyes, Soosan Soroosh, Simon Stebbings, Samuel Whittle, Swan Sim Yeap, Chak Sing Lau. 2018 APLAR axial spondyloarthritis treatment recommendations. International Journal of Rheumatic Diseases 2019; 22(3): 340 doi: 10.1111/1756-185X.13510
|
| 37 |
K. Algate, D. R. Haynes, P. M. Bartold, T. N. Crotti, M. D. Cantley. The effects of tumour necrosis factor‐α on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes. Journal of Periodontal Research 2016; 51(5): 549 doi: 10.1111/jre.12339
|
| 38 |
S. Piaserico, P. Dapavo, A. Conti, P. Gisondi, F.P. Russo. Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature. Journal of the European Academy of Dermatology and Venereology 2017; 31(11): 1853 doi: 10.1111/jdv.14146
|
| 39 |
Jacob Zaemes, Muneeb Rehman, Coleman Smith, Ruth He. Immune Checkpoint Inhibitors - New Insights and Recent Progress. 2023; doi: 10.5772/intechopen.107097
|
| 40 |
Joel V. Chua, John W. Baddley. Infectious Complications in Biologic and Targeted Therapies. 2022; : 69 doi: 10.1007/978-3-031-11363-5_5
|
| 41 |
Marta Priora, Cristina Realmuto, Simone Parisi, Maria C. Ditto, Richard Borrelli, Clara L. Peroni, Angela Laganà, Enrico Fusaro. Rheumatologic manifestations of hepatitis C in the era of direct-acting antiviral agents. Minerva Gastroenterologica e Dietologica 2020; 66(3) doi: 10.23736/S1121-421X.20.02680-X
|
| 42 |
Leonardo Pescitelli, Linda Lazzeri, Lara Tripo, Federica Ricceri, Antonella Di Cesare, Francesca Prignano. Safety and efficacy of HCV eradication during etanercept treatment for severe psoriasis. Dermatologic Therapy 2018; 31(4): e12614 doi: 10.1111/dth.12614
|
| 43 |
Dan Wu, Qiuhong Gu, Ning Zhao, Fei Xia, Zhiwei Li. Structure-based rational design of peptide hydroxamic acid inhibitors to target tumor necrosis factor-αconverting enzyme as potential therapeutics for hepatitis. Journal of Drug Targeting 2015; 23(10): 936 doi: 10.3109/1061186X.2015.1043916
|
| 44 |
Stefano Piaserico, Francesco Messina, Francesco Paolo Russo. Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations. American Journal of Clinical Dermatology 2019; 20(6): 829 doi: 10.1007/s40257-019-00457-3
|
| 45 |
Enrique Rodríguez de Santiago, Agustín Albillos Martínez, Antonio López-Sanromán. Infections in inflammatory bowel disease. Medicina Clínica (English Edition) 2017; 148(9): 415 doi: 10.1016/j.medcle.2017.04.020
|
| 46 |
Karina Bonfiglioli. Cuidados para prescrição de biológicos: atualizações no rastreamento e seguimento com ênfase no risco infeccioso. Revista Paulista de Reumatologia 2017; (2017 jan-mar;16(1)): 6 doi: 10.46833/reumatologiasp.2017.16.1.6-9
|
| 47 |
J.M. Carrascosa, M. Galán, R. de Lucas, A. Pérez-Ferriols, M. Ribera, I. Yanguas. Expert Recommendations on Treating Psoriasis in Special Circumstances (Part II). Actas Dermo-Sifiliográficas (English Edition) 2016; 107(9): 712 doi: 10.1016/j.adengl.2016.08.018
|
| 48 |
Mary Jane Burton, Jeffrey R. Curtis, Shuo Yang, Lang Chen, Jasvinder A. Singh, Ted R. Mikuls, Kevin L. Winthrop, John W. Baddley. Safety of Biologic and Nonbiologic Disease-modifying Antirheumatic Drug Therapy in Veterans with Rheumatoid Arthritis and Hepatitis C Virus Infection. The Journal of Rheumatology 2017; 44(5): 565 doi: 10.3899/jrheum.160983
|
| 49 |
Igor Snast, Lihi Atzmony, Marius Braun, Emmilia Hodak, Lev Pavlovsky. Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature. Journal of the American Academy of Dermatology 2017; 77(1): 88 doi: 10.1016/j.jaad.2017.01.037
|
| 50 |
Kavita Darji, Daniel J. No, Mina Amin, Jashin J. Wu. Clinical Cases in Psoriasis. 2017; : 151 doi: 10.1007/978-3-319-52779-6_20
|
| 51 |
Monica I. Ardura, Sandra C. Kim. Pediatric Inflammatory Bowel Disease. 2023; : 687 doi: 10.1007/978-3-031-14744-9_49
|
| 52 |
Mark Robbins, Karen Doucette. Infectious Complications in Biologic and Targeted Therapies. 2022; : 431 doi: 10.1007/978-3-031-11363-5_23
|
| 53 |
Luisa Costa, Francesco Caso, Antonio Del Puente, Matteo Nicola Dario Di Minno, Rosario Peluso, Raffaele Scarpa. Incidence of Malignancies in a Cohort of Psoriatic Arthritis Patients Taking Traditional Disease Modifying Antirheumatic Drug and Tumor Necrosis Factor Inhibitor Therapy: An Observational Study. The Journal of Rheumatology 2016; 43(12): 2149 doi: 10.3899/jrheum.160542
|
| 54 |
Medi Kori, Kazim Yalcin Arga. Pathways involved in viral oncogenesis: New perspectives from virus-host protein interactomics. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(10): 165885 doi: 10.1016/j.bbadis.2020.165885
|
| 55 |
Alexis Ogdie, Sergio Schwartzman, M. Elaine Husni. Recognizing and managing comorbidities in psoriatic arthritis. Current Opinion in Rheumatology 2015; 27(2): 118 doi: 10.1097/BOR.0000000000000152
|
| 56 |
Monica I. Ardura, Sandra C. Kim. Pediatric Inflammatory Bowel Disease. 2017; : 605 doi: 10.1007/978-3-319-49215-5_49
|
| 57 |
I. Puzanov, A. Diab, K. Abdallah, C. O. Bingham, C. Brogdon, R. Dadu, L. Hamad, S. Kim, M. E. Lacouture, N. R. LeBoeuf, D. Lenihan, C. Onofrei, V. Shannon, R. Sharma, A. W. Silk, D. Skondra, M. E. Suarez-Almazor, Y. Wang, K. Wiley, H. L. Kaufman, M. S. Ernstoff. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group. Journal for ImmunoTherapy of Cancer 2017; 5(1) doi: 10.1186/s40425-017-0300-z
|
| 58 |
Fatima Tahir, Mariya Farooq, Maliha Ashraf Malik, Sobia Manzoor. Extracellular Vesicles Contribute to Viral-Induced Hepatocellular Carcinoma: Understanding Their Involvement in Viral Hepatitis and Their Potential as Biomarkers for Early Hepatocellular Carcinoma Detection. Viral Immunology 2024; 37(3): 159 doi: 10.1089/vim.2023.0151
|
| 59 |
Anwar Al Hammadi, Muna Al Murrawi, Huda R. Ali, Ashraf M. Reda, Hussein A. Dayem, Jawaher Alnaqbi, Zaidoon Abdelhadi, Samir Hantirah, Ayman Alnaeem, Fatima Al. Marzooqi, Amani Alfalasi, Fatima Albreiki, Khadija Aljefri, Faiza Al Ali. Systemic Treatments for Adult Patients with Moderate-to-Severe Psoriasis:
Consensus Statements for the United Arab Emirates. New Emirates Medical Journal 2022; 3(1): 17 doi: 10.2174/02666211213145047
|
| 60 |
Alan Menter, Bruce E. Strober, Daniel H. Kaplan, Dario Kivelevitch, Elizabeth Farley Prater, Benjamin Stoff, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn M.R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Arthur Kavanaugh, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Reena N. Rupani, Michael Siegel, Emily B. Wong, Jashin J. Wu, Vidhya Hariharan, Craig A. Elmets. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. Journal of the American Academy of Dermatology 2019; 80(4): 1029 doi: 10.1016/j.jaad.2018.11.057
|
| 61 |
Miguel Cordero-Coma, Raquel Salazar-Méndez, Taygan Yilmaz. Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues. Expert Opinion on Drug Safety 2015; 14(9): 1353 doi: 10.1517/14740338.2015.1061992
|
| 62 |
Cristiano Pagnini, Kristen O Arseneau, Fabio Cominelli. Safety considerations when using anti-TNFα therapy to treat Crohn’s disease. Expert Opinion on Drug Safety 2015; 14(1): 31 doi: 10.1517/14740338.2015.976610
|
| 63 |
Manuel Pombo-Suarez, Juan J. Gomez-Reino. Infections in Systemic Autoimmune Diseases: Risk Factors and Management. Handbook of Systemic Autoimmune Diseases 2020; 16: 179 doi: 10.1016/B978-0-444-64217-2.00009-9
|
| 64 |
Jasvinder A. Singh, Kenneth G. Saag, S. Louis Bridges, Elie A. Akl, Raveendhara R. Bannuru, Matthew C. Sullivan, Elizaveta Vaysbrot, Christine McNaughton, Mikala Osani, Robert H. Shmerling, Jeffrey R. Curtis, Daniel E. Furst, Deborah Parks, Arthur Kavanaugh, James O'Dell, Charles King, Amye Leong, Eric L. Matteson, John T. Schousboe, Barbara Drevlow, Seth Ginsberg, James Grober, E. William St.Clair, Elizabeth Tindall, Amy S. Miller, Timothy McAlindon. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care & Research 2016; 68(1): 1 doi: 10.1002/acr.22783
|
| 65 |
Virginia Martinez-Santana, Esther Rodriguez-Murphy, Alex Smithson, Nuria Miserachs-Aranda, Ruben del Río-Gil, Inmaculada Torre-Lloverás. Efficacy and safety of direct-acting antiviral agents when combined with secukinumab. European Journal of Hospital Pharmacy 2018; 25(1): 53 doi: 10.1136/ejhpharm-2017-001212
|
| 66 |
V. V. Onipchenko, I. G. Sergeeva, Yu. M. Krinitsyina, A. A. Kondrashova, V. V. Pahomova, N. V. Hismatulina. Anti-cytokine therapy of a patient suffering from psoriatic arthritis. Vestnik dermatologii i venerologii 2016; 92(4): 54 doi: 10.25208/0042-4609-2016-92-4-54-58
|
| 67 |
Lesley J. Scott. Etanercept: A Review of Its Use in Autoimmune Inflammatory Diseases. Drugs 2014; 74(12): 1379 doi: 10.1007/s40265-014-0258-9
|
| 68 |
Yi-Ming Chen, Hsin-Hua Chen, Yi-Hsing Chen, Tsu-Yi Hsieh, Chia-Wei Hsieh, Wei-Ting Hung, Joung-Liang Lan, Der-Yuan Chen. A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C. Annals of the Rheumatic Diseases 2015; 74(3): 626 doi: 10.1136/annrheumdis-2014-206711
|
| 69 |
Luis A. Gómez-García, Maira E. Herz-Ruelas, Airam Regalado-Ceballos, Jorge Ocampo-Candiani. Manifestaciones cutáneas de la hepatitis vírica en la era de los nuevos agentes antivirales. Piel 2022; 37(6): 350 doi: 10.1016/j.piel.2021.10.006
|
| 70 |
Elías Forero, Monique Chalem, Gloria Vásquez, Edwin Jauregui, Luis Fernando Medina, Luis Fernando Pinto Peñaranda, John Medina, Yimy Medina, Diego Jaimes, Ana Milena Arbelaez, Aura María Domínguez, Andrés Fernández, Oscar Jair Felipe-Díaz, Philippe Chalem, Carlo Vinicio Caballero Uribe, María José Jannaut, Ixhel García, Wilson Bautista, Javier Ramírez Figueroa, Jorge Cortés, Jorge Quintero, Nohora Rodríguez. Gestión de riesgo para la prescripción de terapias biológicas. Revista Colombiana de Reumatología 2016; 23(1): 50 doi: 10.1016/j.rcreu.2016.02.004
|
| 71 |
Jacqueline Moreau, Erica Bromberg, Laura Korb Ferris. Psoriatic Arthritis and Psoriasis. 2016; : 281 doi: 10.1007/978-3-319-19530-8_28
|
| 72 |
Ayman Abdelmaksoud, Michelangelo Vestita. Anti-HCV for treatment of HCV-positive psoriatic patients: A promising therapy. Dermatologic Therapy 2018; 31(6): e12736 doi: 10.1111/dth.12736
|
| 73 |
Eduardo Uchiyama, George N. Papaliodis, Ann-Marie Lobo, Lucia Sobrin. Side-Effects of Anti-Inflammatory Therapy in Uveitis. Seminars in Ophthalmology 2014; 29(5-6): 456 doi: 10.3109/08820538.2014.959203
|
| 74 |
Hyun Mi Kwon, Kichul Shin, Jin Young Moon, Shin-Seok Lee, Won Tae Chung, Jisoo Lee, Sang-Heon Lee, Seong-Wook Kang, Chang Hee Suh, Seung-Jae Hong, Ran Song, Jung-Yoon Choe, Yeong Wook Song. Transaminase Changes in Korean Rheumatoid Arthritis Patients with Chronic Hepatitis C after Biologic Therapy. Journal of Rheumatic Diseases 2018; 25(2): 108 doi: 10.4078/jrd.2018.25.2.108
|
| 75 |
Claudio Bonifati, Viviana Lora, Dario Graceffa, Lorenzo Nosotti. Management of psoriasis patients with hepatitis B or hepatitis C virus infection. World Journal of Gastroenterology 2016; 22(28): 6444-6455 doi: 10.3748/wjg.v22.i28.6444
|